Scientific Standards for Studies on Modified Risk Tobacco Products (2012)
Chapter: Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix A: Section 911 of the Family Smoking Prevention and Tobacco Control Act of 2009
Next Chapter: [Appendix B] 1 Introduction
Suggested Citation:
"Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press.
doi: 10.17226/13294.
Chapters 1 and 2 from
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease1
_______________
1 Institute of Medicine. 2010. Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington, DC: The National Academies Press
Suggested Citation:
"Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press.
doi: 10.17226/13294.
Suggested Citation:
"Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press.
doi: 10.17226/13294.
Suggested Citation:
"Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press.
doi: 10.17226/13294.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.